tiprankstipranks
Novavax (NVAX)
NASDAQ:NVAX
US Market

Novavax (NVAX) Income Statement

Compare
9,786 Followers

Novavax Income Statement

Last quarter (Q3 2024), Novavax's total revenue was $84.51M, an increase of 283.03% from the same quarter last year. In Q3, Novavax's net income was $-121.30M. See Novavax’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 682.16M$ 556.38M$ 1.60B$ 1.15B$ 475.60M
Gross Profit
$ 479.42M$ 212.61M$ 696.31M$ 1.13B$ -271.43M
Operating Expenses
$ 728.35M$ 779.13M$ 1.34B$ 2.83B$ 892.32M
Depreciation and Amortization
$ 0.00$ 41.23M$ 29.05M$ 12.66M$ 4.88M
EBITDA
$ -248.93M$ -487.39M$ -604.71M$ -1.68B$ -398.23M
Operating Income
$ -248.93M$ -566.51M$ -644.74M$ -1.69B$ -416.72M
Other Income/Expenses
$ 72.32M$ 23.48M$ -8.91M$ -27.96M$ -1.54M
Pretax Income
$ -176.62M$ -543.03M$ -653.65M$ -1.71B$ -418.26M
Net Income
$ -187.50M$ -545.06M$ -657.94M$ -1.74B$ -427.50M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.23$ -5.41$ -8.42$ -23.44$ -7.43
Diluted EPS
$ -1.23$ -5.41$ -8.42$ -23.44$ -7.43
Weighted Average Shares Outstanding
152.19M 100.77M 78.18M 74.40M 57.55M
Weighted Average Shares Outstanding (Diluted)
152.19M 100.77M 78.18M 74.40M 57.55M
Currency in USD

Novavax Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis